Salt Lake City, Utah – A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah, is testing a new combination drug therapy that could both treat and prevent melanoma metastasis, or spreading from its original site, to...

Hinxton, England – For the first time, scientists have systematically analysed somatic mutations in stomach lining tissue to unpick mutational processes, some of which can lead to cancer. The team also uncovered hints of a potential new cause of stomach cancer that needs further research. Researchers at the Wellcome Sanger...

PRINCETON, N.J. – Bristol Myers Squibb (NYSE: BMY) announced that the European Commission (EC) has granted approval to Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy....